These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
244 related articles for article (PubMed ID: 36623929)
21. Resting-State Functional Connectivity Predicts STN DBS Clinical Response. Younce JR; Campbell MC; Hershey T; Tanenbaum AB; Milchenko M; Ushe M; Karimi M; Tabbal SD; Kim AE; Snyder AZ; Perlmutter JS; Norris SA Mov Disord; 2021 Mar; 36(3):662-671. PubMed ID: 33211330 [TBL] [Abstract][Full Text] [Related]
22. Parkinson's disease progression at 30 years: a study of subthalamic deep brain-stimulated patients. Merola A; Zibetti M; Angrisano S; Rizzi L; Ricchi V; Artusi CA; Lanotte M; Rizzone MG; Lopiano L Brain; 2011 Jul; 134(Pt 7):2074-84. PubMed ID: 21666262 [TBL] [Abstract][Full Text] [Related]
23. Brain networks modulated by subthalamic nucleus deep brain stimulation. Accolla EA; Herrojo Ruiz M; Horn A; Schneider GH; Schmitz-Hübsch T; Draganski B; Kühn AA Brain; 2016 Sep; 139(Pt 9):2503-15. PubMed ID: 27412387 [TBL] [Abstract][Full Text] [Related]
24. Deep brain stimulation of the subthalamic nucleus improves sense of well-being in Parkinson's disease. McDonald LM; Page D; Wilkinson L; Jahanshahi M Mov Disord; 2012 Mar; 27(3):372-8. PubMed ID: 22411848 [TBL] [Abstract][Full Text] [Related]
25. Involvement of the subthalamic nucleus in impulse control disorders associated with Parkinson's disease. Rodriguez-Oroz MC; López-Azcárate J; Garcia-Garcia D; Alegre M; Toledo J; Valencia M; Guridi J; Artieda J; Obeso JA Brain; 2011 Jan; 134(Pt 1):36-49. PubMed ID: 21059746 [TBL] [Abstract][Full Text] [Related]
27. Subthalamic deep brain stimulation sweet spots and hyperdirect cortical connectivity in Parkinson's disease. Akram H; Sotiropoulos SN; Jbabdi S; Georgiev D; Mahlknecht P; Hyam J; Foltynie T; Limousin P; De Vita E; Jahanshahi M; Hariz M; Ashburner J; Behrens T; Zrinzo L Neuroimage; 2017 Sep; 158():332-345. PubMed ID: 28711737 [TBL] [Abstract][Full Text] [Related]
28. Deep brain stimulation of the subthalamic nucleus transiently enhances loss-chasing behaviour in patients with Parkinson's disease. Rogers RD; Wielenberg B; Wojtecki L; Elben S; Campbell-Meiklejohn D; Schnitzler A Exp Neurol; 2011 Sep; 231(1):181-9. PubMed ID: 21726554 [TBL] [Abstract][Full Text] [Related]
29. Subthalamic dynamic neural states correlate with motor symptoms in Parkinson's Disease. Nie Y; Luo H; Li X; Geng X; Green AL; Aziz TZ; Wang S Clin Neurophysiol; 2021 Nov; 132(11):2789-2797. PubMed ID: 34592557 [TBL] [Abstract][Full Text] [Related]
30. Neuromodulation of the subthalamic nucleus in Parkinson's disease: the effect of fiber tract stimulation on tremor control. Abdulbaki A; Kaufmann J; Galazky I; Buentjen L; Voges J Acta Neurochir (Wien); 2021 Jan; 163(1):185-195. PubMed ID: 33174115 [TBL] [Abstract][Full Text] [Related]
31. Subthalamic nucleus deep brain stimulation for Parkinson's disease: evidence for effectiveness and limitations from 12 years' experience. ; Chan AY; Yeung JH; Mok VC; Ip VH; Wong A; Kuo SH; Chan DT; Zhu XL; Wong E; Lau CK; Wong RK; Tang V; Lau C; Poon WS Hong Kong Med J; 2014 Dec; 20(6):474-80. PubMed ID: 25345997 [TBL] [Abstract][Full Text] [Related]
32. Stimulation of the caudal zona incerta is superior to stimulation of the subthalamic nucleus in improving contralateral parkinsonism. Plaha P; Ben-Shlomo Y; Patel NK; Gill SS Brain; 2006 Jul; 129(Pt 7):1732-47. PubMed ID: 16720681 [TBL] [Abstract][Full Text] [Related]
33. Use of Functional Magnetic Resonance Imaging to Assess How Motor Phenotypes of Parkinson's Disease Respond to Deep Brain Stimulation. DiMarzio M; Madhavan R; Joel S; Hancu I; Fiveland E; Prusik J; Gillogly M; Rashid T; MacDonell J; Ashe J; Telkes I; Feustel P; Staudt MD; Shin DS; Durphy J; Hwang R; Hanspal E; Pilitsis JG Neuromodulation; 2020 Jun; 23(4):515-524. PubMed ID: 32369255 [TBL] [Abstract][Full Text] [Related]
34. Multiple-source current steering in subthalamic nucleus deep brain stimulation for Parkinson's disease (the VANTAGE study): a non-randomised, prospective, multicentre, open-label study. Timmermann L; Jain R; Chen L; Maarouf M; Barbe MT; Allert N; Brücke T; Kaiser I; Beirer S; Sejio F; Suarez E; Lozano B; Haegelen C; Vérin M; Porta M; Servello D; Gill S; Whone A; Van Dyck N; Alesch F Lancet Neurol; 2015 Jul; 14(7):693-701. PubMed ID: 26027940 [TBL] [Abstract][Full Text] [Related]